Navigation Links
Positive Trial Results, Completed Acquisitions, and Clearances - Research Report on Dyax, IPC, Array BioPharma, Lexicon Pharmaceuticals, and Wright Medical
Date:12/20/2013

ake mistakes. If you notice any errors or omissions, please notify us below.
  • This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  • If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  • For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  • Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

  • COMPLIANCE PROCEDURE

    Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

    NOT FINANCIAL ADVICE

    Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

    NO WARRANTY OR LIABILITY ASSUMED

    Equity News Network is not responsible f
    '/>"/>

    SOURCE Analysts' Corner
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol
    2. According to Surveyed U.S. Oncologists, Perjeta is Prescribed to Over One-Third of First-Line Advanced/Metastatic HER2-Positive, HR-Negative Breast Cancer Patients
    3. BioLineRx Presents Positive Preclinical Results of Acute Myeloid Leukemia Treatment at ASH Conference
    4. Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65
    5. Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures
    6. Annual General Meeting Schedules, New Drug Applications, Positive Study Results, Conference Participations, and Secondary Offerings - Research Report on Mindray, AcelRx, Merrimack, ZELTIQ, and Clovis
    7. Dividends, Recognitions, Positive Opinions, Share Repurchase Programs, and Award Programs - Research Report on BD, Sanofi, GSK, Agilent Technologies, and Align Technology
    8. According to Surveyed EU5 Oncologists, Zelboraf Captures 50 Percent Patient Share of the First-Line BRAF-Mutation Positive Malignant Melanoma Population
    9. Positive FDA Meeting Confirms BDSI Phase 3 Program for Clonidine Topical Gel for Treatment of Painful Diabetic Neuropathy
    10. Positive Opinion, Stock Price Movement, and Executive Appointments - Research Report on Celgene, Sirona, Centene, Fresenius Medical Care, and PerkinElmer
    11. According to Surveyed U.S. Oncologists, Zelboraf is the Patient Share Leader in First-Line BRAF-Mutation Positive Malignant Melanoma
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... HILL, N.C. , Dec. 23, 2014  Medical ... success. As the key link between the medical device ... grow even more in the coming years as the ... According to research by benchmarking firm, ... MSLs can gain an important edge is by harnessing ...
    (Date:12/22/2014)... VIEJO, Calif. , Dec. 22, 2014 ... into expanded corporate offices in Aliso Viejo ... announced that due to the tremendous growth and worldwide ... needed. Sales of patented SnoreRx, the anti snore cure ... offices. He said, "We are now in 23 ...
    (Date:12/22/2014)... , Dec. 22, 2014 Research and ... the addition of the "Investment Analysis of ... to their offering. ... in the US medical device sector identifies the ... and venture capital investments, and mergers and acquisitions. ...
    Breaking Medicine Technology:Role of Medical Science Liaisons Evolving in Medical Device Sector 2Investment Analysis of the US Medical Device Sector 2
    ... Safety Concerns Raised ... NEW YORK, Dec. 5 Keryx Biopharmaceuticals,(Nasdaq: KERX ... (DSMC) responsible for monitoring Sulonex(TM) (sulodexide oral,gelcaps), the Company,s ... nephropathy, recently met to evaluate the data from,the ongoing ...
    ... N.J., Dec. 5 Senesco,Technologies, Inc. ("Senesco" or ... it has initiated preclinical lab studies at Mayo ... test the ability of,Senesco,s Factor 5A gene technology ... will evaluate delivery molecules for,encapsulation of Factor 5A ...
    Cached Medicine Technology:Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data 2Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data 3Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data 4Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data 5Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data 6Senesco Technologies Initiates Preclinical Studies for Cancer Target 2
    (Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
    (Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
    (Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
    (Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
    (Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
    Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
    ... wheat that boosts up the protein, zinc and iron ... that affect millions of children worldwide. Researchers at the ... the U.S. Department of Agriculture; and the University of ... the Nov. 24 issue of the journal Science. ...
    ... there is one more impact of a job burn out. ... also stir up a host of ailments, say Scientists. //This ... stress at work can contribute to high blood pressure, metabolic ... 677 workers in Israel revealed that risk of Type 2 ...
    ... School of Medicine have reported that genetics has a ... preemies//, a disease known to hamper the development of ... This report is published in the November issue of ... show that genetic factors are a significant component of ...
    ... Scientists at San Francisco, in the US, have announced ... positive results. // ,This treatment referred to as ... of brain cancer, termed glioma.Scientists at the University of ... mode of treatment involves isolating a protein gp96 from ...
    ... Vietnam, The Nha Trang Institute of Vaccines and Biological ... 5,000 doses of a H5N1 vaccine for// humans from ... on white mice, guinea-pigs and cockerels and similar reactions ... Institute of Verification of Vaccines and Biological Products. Its ...
    ... Michelle Hasni of Cutler Ridge, Miami, delivered a male child ... very rare congenital heart disorder called Ectopia// cordis. Seven or ... defect. ,The baby named Naseem, was born with ... and the protective cover for the heart called pericardium had ...
    Cached Medicine News:Health News:Newly Cloned Wheat Gene May Boosts Foods' Nutrient Contents – Says A Researc 2Health News:Genetics Plays A Crucial Role In Preemies' Destructive Eye Disease 2Health News:Naseem’s Heart Put In Its Plac 2
    ... Size: 5.0 x 2.5 x 80 mm. Half ... by Harvey A. Lincoff, M.D. has been modified ... design. The material is a closed cell sponge ... with rounded edges to minimize scleral intrusion. These ...
    ... mm. Storz offers the original Scleral ... A. Lincoff, M.D. The material is ... non-toxic and non-antigenic. Implants are soft ... intrusion. These implants are packaged sterile ...
    For use under curved implants. Indications: When additional buckling is required in the meridional direction. Overall length: 15.0 mm....
    For use under silicone strips E5381 610, E5381 611 and E5381 710. Indications: When higher buckle is required. Overall length: 6.1 mm....
    Medicine Products: